Thrombotic microangiopathy: Eculizumab for atypical haemolytic uraemic syndrome: what next?
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2013 |
|---|---|
| Erschienen: |
2013 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Nature clinical practice / Nephrology - 9(2013), 9 vom: 23. Sept., Seite 495-496 |
| Beteiligte Personen: |
Fakhouri, Fadi [VerfasserIn] |
|---|
| Umfang: |
2 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1926389018 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1926389018 | ||
| 003 | DE-627 | ||
| 005 | 20230514040310.0 | ||
| 007 | tu | ||
| 008 | 130826s2013 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw130824_1 |
| 035 | |a (DE-627)OLC1926389018 | ||
| 035 | |a (DE-599)GBVOLC1926389018 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 610 |
| 100 | 1 | |a Fakhouri, Fadi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Thrombotic microangiopathy: Eculizumab for atypical haemolytic uraemic syndrome: what next? |
| 264 | 1 | |c 2013 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Frémeaux-Bacchi, Véronique |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Nature clinical practice / Nephrology |d New York, NY : Nature Publ. Group, 2005 |g 9(2013), 9 vom: 23. Sept., Seite 495-496 |w (DE-627)509759076 |w (DE-600)2228557-X |w (DE-576)262269104 |x 1745-8323 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2013 |g number:9 |g day:23 |g month:09 |g pages:495-496 |g extent:2 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2013 |e 9 |b 23 |c 9 |h 495-496 |g 2 | ||